MedPath

The long term effectiveness of 40% salicylic acid plasters on corns

Phase 1
Conditions
Corns
MedDRA version: 9.1 Level: LLT Classification code 10011064 Term: Corns
Registration Number
EUCTR2008-005313-21-GB
Lead Sponsor
Sheffield Health and Social Research Consortium
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
Not specified
Target Recruitment
308
Inclusion Criteria

Adult patients with corns, patients who are willing to take part for the duration of the study and patients who have the capability to make an informed decision and give informed consent.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Patients with: diabetes, impaired lower limb circulation, a history of foot ulceration, rheumatoid arthrtitis, taking oral steriod medication, who have dermatological conditions, who are allergic to Zinc Oxide plaster, allertgic to salicylic acid, patient with neuropathy, patients unable to reach their feet, patients with callus and no corns, patients with infected or neurovascular corns, patients who are pregnant or breast feeding, patients with a peanut or soya allergy.

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Main Objective: To evaluate the long term effectiveness of 40% salicylic acid plasters on corns when compared with 'usual' treatment which is scalpel debridement in terms of the proportion of unhealed or recurrent corns remaining over a 12-month period.;Secondary Objective: To evaluate the cost-effectiveness of corn plasters compared with scalpel corn removal, to compare patient centred outcomes in terms of pain, foot disability and quality of life and satisfaction. To explore podiatrists' views of the two treatments.;Primary end point(s): Presence at 3 months post randomisation of an unhealed or recurrent corn that requires further ongoing treatment.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath